Literature DB >> 11469726

Cytochromes P450 in brain: function and significance.

H W Strobel1, C M Thompson, L Antonovic.   

Abstract

The presence and activity of cytochromes P450 in brain regions and various brain cells have been extended and advanced over the last five years covered by this review. Using in situ hybridization and immunohistochemical techniques, many cytochrome P450 enzymes have been demonstrated to be present in brain and to have a regional rather than universal distribution. Many of these various cytochromes P450 have been shown to catalyze the metabolism of neurosteroids as well as other biologically significant compounds in brain. In addition, many cytochrome P450 enzymes have been implicated in the metabolism of psychoactive drugs such as neuroleptics and antidepressants. The regulation of cytochrome P450 expression has been studied at greater detail, the regulation of aromatase being a prominent example during the last five years.

Mesh:

Substances:

Year:  2001        PMID: 11469726     DOI: 10.2174/1389200013338577

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  18 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model.

Authors:  C Fang; V J Bolivar; J Gu; W Yang; S O Zeitlin; X Ding
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

3.  mRNA distribution and heterologous expression of orphan cytochrome P450 20A1.

Authors:  Katarina Stark; Zhong-Liu Wu; Cheryl J Bartleson; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2008-06-09       Impact factor: 3.922

Review 4.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

5.  Prenatal Exposure of Cypermethrin Induces Similar Alterations in Xenobiotic-Metabolizing Cytochrome P450s and Rate-Limiting Enzymes of Neurotransmitter Synthesis in Brain Regions of Rat Offsprings During Postnatal Development.

Authors:  Anshuman Singh; Anubha Mudawal; Pratibha Maurya; Rajeev Jain; Saumya Nair; Rajendra K Shukla; Sanjay Yadav; Dhirendra Singh; Vinay Kumar Khanna; Rajnish Kumar Chaturvedi; Mohana K R Mudiam; Rao Sethumadhavan; Mohammad Imran Siddiqi; Devendra Parmar
Journal:  Mol Neurobiol       Date:  2015-06-27       Impact factor: 5.590

6.  Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.

Authors:  Jibran Y Khokhar; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

7.  Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs.

Authors:  Annalisa Nannelli; Francesco Rossignolo; Roberto Tolando; Paolo Rossato; Mario Pellegatti; Vincenzo Longo; P Giovanni Gervasi
Journal:  Mol Cell Biochem       Date:  2009-10-22       Impact factor: 3.396

Review 8.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells.

Authors:  Nidhi Kapoor; Aditya B Pant; Alok Dhawan; Uppendra N Dwievedi; Prahlad K Seth; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2007-07-24       Impact factor: 3.396

10.  Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration.

Authors:  Rong Zhao; J Cory Kalvass; Souzan B Yanni; Arlene S Bridges; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2008-12-29       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.